Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
BMC Genomics ; 23(1): 42, 2022 Jan 10.
Artículo en Inglés | MEDLINE | ID: mdl-35012468

RESUMEN

BACKGROUND: Alternative splicing is a key mechanism underlying cellular differentiation and a driver of complexity in mammalian neuronal tissues. However, understanding of which isoforms are differentially used or expressed and how this affects cellular differentiation remains unclear. Long read sequencing allows full-length transcript recovery and quantification, enabling transcript-level analysis of alternative splicing processes and how these change with cell state. Here, we utilise Oxford Nanopore Technologies sequencing to produce a custom annotation of a well-studied human neuroblastoma cell line SH-SY5Y, and to characterise isoform expression and usage across differentiation. RESULTS: We identify many previously unannotated features, including a novel transcript of the voltage-gated calcium channel subunit gene, CACNA2D2. We show differential expression and usage of transcripts during differentiation identifying candidates for future research into state change regulation. CONCLUSIONS: Our work highlights the potential of long read sequencing to uncover previously unknown transcript diversity and mechanisms influencing alternative splicing.


Asunto(s)
Nanoporos , Empalme del ARN , Empalme Alternativo , Animales , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Isoformas de Proteínas/genética
3.
Genes (Basel) ; 12(5)2021 04 25.
Artículo en Inglés | MEDLINE | ID: mdl-33922969

RESUMEN

Genomic imprinting, an epigenetic phenomenon that causes the expression of a small set of genes in a parent-of-origin-specific manner, is thought to have co-evolved with placentation. Many imprinted genes are expressed in the placenta, where they play diverse roles related to development and nutrient supply function. However, only a small number of imprinted genes have been functionally tested for a role in nutrient transfer capacity in relation to the structural characteristics of the exchange labyrinthine zone. Here, we examine the transfer capacity in a mouse model deficient for the maternally expressed Phlda2 gene, which results in placental overgrowth and a transient reduction in fetal growth. Using stereology, we show that the morphology of the labyrinthine zone in Phlda2-/+ mutants is normal at E16 and E19. In vivo placental transfer of radiolabeled solutes 14C-methyl-D-glucose and 14C-MeAIB remains unaffected at both gestational time points. However, placental passive permeability, as measured using two inert hydrophilic solutes (14C-mannitol; 14C-inulin), is significantly higher in mutants. Importantly, this increase in passive permeability is associated with fetal catch-up growth. Our findings uncover a key role played by the imprinted Phlda2 gene in modifying placental passive permeability that may be important for determining fetal growth.


Asunto(s)
Intercambio Materno-Fetal , Proteínas Nucleares/genética , Placenta/metabolismo , 3-O-Metilglucosa/farmacocinética , Animales , Femenino , Eliminación de Gen , Impresión Genómica , Inulina/farmacocinética , Manitol/farmacocinética , Ratones , Ratones Endogámicos C57BL , Proteínas Nucleares/metabolismo , Embarazo , beta-Alanina/análogos & derivados , beta-Alanina/farmacocinética
4.
Reprod Biomed Online ; 25(1): 68-89, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22560117

RESUMEN

The placenta is a transient organ found in eutherian mammals that evolved primarily to provide nutrients for the developing fetus. The placenta exchanges a wide array of nutrients, endocrine signals, cytokines and growth factors with the mother and the fetus, thereby regulating intrauterine development. Recent studies show that the placenta is not just a passive organ mediating maternal-fetal exchange. It can adapt its capacity to supply nutrients in response to intrinsic and extrinsic variations in the maternal-fetal environment. These dynamic adaptations are thought to occur to maximize fetal growth and viability at birth in the prevailing conditions in utero. However, some of these adaptations may also affect the development of individual fetal tissues, with patho-physiological consequences long after birth. Here, this review summarizes current knowledge on the causes, possible mechanisms and consequences of placental adaptive responses, with a focus on the regulation of transporter-mediated processes for nutrients. This review also highlights the emerging roles that imprinted genes and epigenetic mechanisms of gene regulation may play in placental adaptations to the maternal-fetal environment.


Asunto(s)
Adaptación Fisiológica/fisiología , Desarrollo Fetal/fisiología , Intercambio Materno-Fetal/fisiología , Placenta/fisiología , Fenómenos Fisiologicos de la Nutrición Prenatal/fisiología , Aminoácidos/metabolismo , Animales , Calcio/metabolismo , Epigénesis Genética , Femenino , Feto/metabolismo , Ácido Fólico/metabolismo , Regulación del Desarrollo de la Expresión Génica , Impresión Genómica/fisiología , Edad Gestacional , Glucosa/metabolismo , Humanos , Embarazo , Transducción de Señal
5.
FASEB J ; 25(5): 1737-45, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21282203

RESUMEN

The healthy development of the fetus depends on an optimal balance between fetal genetic drive for growth and the maternal ability to provide nutrients through the placenta. Nothing is known about fetal-placental signaling in response to increased fetal demand in the situation of overgrowth. Here, we examined this question using the H19(Δ13) mouse model, shown previously to result in elevated levels of Igf2. Fetal and placental weights in H19(Δ13) were increased by 23% and 45%, respectively, at E19, when compared with wild-type mice. Unexpectedly, we found that disproportionately large H19(Δ13) placentas transport 20-35% less (per gram placenta) glucose and system A amino acids and have similar reductions in passive permeability, despite a significantly greater surface area for nutrient exchange and theoretical diffusion capacity compared with wild-type mice. Expression of key transporter genes Slc2a3 and Slc38a4 was reduced by ∼20%. Decreasing the overgrowth of the H19(Δ13) placenta by genetically reducing levels of Igf2P0 resulted in up-regulation of system A activity and maintenance of fetal overgrowth. Our results provide direct evidence that large placentas can modify their nutrient transfer capacity to regulate fetal nutrient acquisition. Our findings are indicative of fetal-placental signaling mechanisms that limit total demand for maternal nutrients.


Asunto(s)
Feto/metabolismo , Factor II del Crecimiento Similar a la Insulina/metabolismo , Animales , Femenino , Desarrollo Fetal/genética , Desarrollo Fetal/fisiología , Genotipo , Factor II del Crecimiento Similar a la Insulina/genética , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Mutantes , Placenta/metabolismo , Embarazo , ARN Largo no Codificante , ARN no Traducido/genética
6.
Proc Natl Acad Sci U S A ; 102(52): 19219-24, 2005 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-16365304

RESUMEN

The mammalian fetus is unique in its dependence during gestation on the supply of maternal nutrients through the placenta. Maternal supply and fetal demand for nutrients need to be fine tuned for healthy growth and development of the fetus along its genetic trajectory. An altered balance between supply and demand can lead to deviations from this trajectory with long-term consequences for health. We have previously shown that in a knockout lacking the imprinted placental-specific Igf2 transcript (P0), growth of the placenta is compromised from early gestation but fetal growth is normal until late gestation, suggesting functional adaptation of the placenta to meet the fetal demands. Here, we show that placental transport of glucose and amino acids are increased in the Igf2 P0(+/-) null and that this up-regulation of transport occurs, at least in part, through increased expression of the transporter genes Slc2a3 and Slc38a4, the imprinted member of the System A amino acid transporter gene family. Decreasing fetal demand genetically by removal of fetal Igf2 abolished up-regulation of both transport systems and reduced placental System A amino acid transport activity and expression of Slc38a2 in late gestation. Our results provide direct evidence that the placenta can respond to fetal demand signals through regulation of expression of specific placental transport systems. Thus, crosstalk between an imprinted growth demand gene (Igf2) and placental supply transporter genes (Slc38a4, Slc38a2, and Slc2a3) may be a component of the genetic control of nutrient supply and demand during mammalian development.


Asunto(s)
Feto/metabolismo , Transportador de Glucosa de Tipo 3/fisiología , Placenta/metabolismo , Proteínas/genética , Alelos , Sistema de Transporte de Aminoácidos A/genética , Sistemas de Transporte de Aminoácidos/genética , Animales , Transporte Biológico , Femenino , Eliminación de Gen , Impresión Genómica , Genotipo , Glucosa/metabolismo , Proteínas Facilitadoras del Transporte de la Glucosa/metabolismo , Transportador de Glucosa de Tipo 3/metabolismo , Factor II del Crecimiento Similar a la Insulina , Operón Lac , Proteínas de Transporte de Membrana/química , Ratones , Ratones Endogámicos C57BL , Modelos Genéticos , Mutación , ARN Mensajero/metabolismo , Factores de Tiempo , Transgenes , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...